|
|
|
|
This article, the first in a two-part series, focuses on the initial stages of product development — specifically, how to move from candidate selection to a Phase 1 Investigational New Drug (IND) application.
|
|
|
|
|
Learn how to plan early and align research, development, and commercial priorities to ensure a seamless transition from clinical development to scalable, cost-efficient commercialization.
|
|
|
|
|
Developers often aim to cut expenses during development. Discover the long-term outcomes of cost-effective measures like using RUO leukopaks compared to investing in high-quality GMP-grade vectors.
|
|
|
|
OUTSOURCED PHARMA CAPACITY UPDATE VIDEO FEATURE
|
|
|
|
|
We're a trusted manufacturing services partner for cell therapy companies, providing expert services including access to CMC development and clinical manufacturing. View our presentation to see how we can help advance your novel therapeutic.
|
|
|
|
|
|
|
